syndrome inborn error cholesterol autosomal recessive multiple malformation syndrome caused mutation enzyme reductase encoded gene causes broad spectrum effects ranging mild intellectual disability behavioural problems lethal slos present differently different cases depending severity mutation factors originally slos patients classified two categories classic severe based physical mental characteristics alongside clinical features since discovery specific biochemical defect responsible slos patients given severity score based levels cerebral ocular oral genital defects used classify patients mild classical severe common facial features slos include microcephaly bitemporal narrowing reduced distance temples ptosis short upturned nose micrognathia epicanthal folds capillary hemangioma physical characteristics certain behaviours attributes commonly seen among patients slos may low normal intelligence react negatively hypersensitivity different sensory stimuli particularly true certain auditory visual stimuli many patients show aggressiveness selfinjurious behaviours sleep disturbances specific behaviours resembling people autism often present well hyperactivity provides genetic biological insights autism spectrum disorders autistic behaviours characteristic slos patients opisthokinesis upper body movement stretching upper body hand autism typically diagnosed separately slos using dsmv approximately slos patients meet criteria behaviours associated slos linked directly physical abnormalities example infants often show feeding problems feeding intolerance patients may require increased caloric intake due accelerated metabolism recurrent infections including ear infections pneumonia also given slos caused mutation enzyme involved cholesterol synthesis resulting biochemical characteristics may predictable patients lowered plasma cholesterol levels hypocholesterolemia however approximately may show normal cholesterol decreased concentrations cholesterol solely indicative slos increased levels cholesterol precursors also common slos particular elevated levels fairly specific gene encoding labeled cloned mapped chromosome base pairs dna length contains nine corresponding mrna base pairs length remaining dna sequence intronic structure rat gene similar structure human highest levels expression detected adrenal gland testis liver brain tissue expression induced decreased sterol concentrations via sterol regulatory binding proteins srebp also evidence activity may regulated tissue specific transcription alternative outlined enzyme catalyzes reduction cholesterol well reduction desmosterol requires nadph cofactor reduction may involve activity oxidoreductase also thought contain integral membrane protein endoplasmic reticulum computer models predicted nine transmembrane efficient reducing known reduce carbon double bond sterols indicating range substrate specificity human version enzyme predicted molecular weight kda isoelectric point amino acid sequence encodes predicted contain amino acids well several protein motifs contains multiple sterol reductase motifs would expected given function contains potential sterolsensing domain ssd whose function unknown thought necessary binding sterol substrates also includes multiple sites phosphorylation including potential protein kinase c tyrosine kinase sites regulatory enzymes responsible phosphorylation exact function phosphorylating yet unknown thought involved regulation slos autosomal recessive different types mutations missense mutations single nucleotide change resulting code different amino acid common accounting slos spectrum typically reduce function enzyme may inhibit completely much depends nature mutation ie amino acid replaced null mutations much less common mutations produce either completely dysfunctional enzyme enzyme thus missense mutations may common overall less lethal nonsense mutations nonsense mutations may simply result spontaneous frequently reported mutation disrupts joining exons eight nine results insertion nucleotides transcript nonsense mutation thus patients homozygous allele severely affected thought mutation first occurred british isles carrier heterozygous allele affected frequency caucasians european heritage frequency mutations differs various ethnicities depending origin mutation caucasian populations particular mutation estimated carrier frequency next common mutation results threonine amino acid position missense mutation tends associated less severe symptoms mutation common one seen patients italian cuban mediterranean third common mutation nonsense mutation causes protein termination enzyme would formed thought arisen southern poland common northern mutations less common although appear target certain protein domains others example sterol reductase motifs common sites overall estimated carrier frequency mutation causing slos caucasian populations less frequent among asian african number indicates hypothetical birth incidence however measured incidence differs depending heritage much lower expected indicates many cases slos undetected likely due either spontaneous abortion caused severe mutations miscarriage mild cases undiagnosed females lack characteristic genital malformations affected males thus less likely correctly cholesterol obtained diet also formed metabolism body cholesterol metabolism primarily takes place liver significant amounts intestine also noted cholesterol pass barrier thus within brain biosynthesis source humans cholesterol synthesis begins mevalonate pathway see diagram leading synthesis farnesyl pyrophosphate fpp pathway uses two acetylcoa two nadph make mevalonate metabolized isopentenyl pyrophosphate ipp using three atp three ipp needed make one fpp combination two fpp leads formation squalene represents first committed step towards cholesterol biosynthesis squalene leads creation lanosterol multiple pathways lead cholesterol biosynthesis rate limiting step cholesterol synthesis conversion hmgcoa mevalonate early step mevalonate pathway catalyzed hmgcoa complicated series reactions lanosterol leads formation zymosterol shown diagram right point pathway diverges humans main pathway leading cholesterol known zymosterol metabolized lathosterol immediate precursor cholesterol enzyme responsible converting reduces double bond carbon leading unesterified mutations enzyme responsible wide range defects present slos another pathway leading cholesterol synthesis required reduction regulation cholesterol synthesis complex occurs primarily enzyme hmgcoa reductase catalyst ratelimiting step involves feedback loop sensitive cellular levels cholesterol four main steps regulation cholesterol important lipid involved metabolism cell function structure structural component cell provides structure regulates fluidity phospholipid bilayer furthermore cholesterol constituent lipid rafts congregations proteins lipids including sphingolipids cholesterol float within cell membrane play role regulation membrane function lipid rafts ordered rigid membrane bilayer surrounding involvement regulation stems mostly association proteins upon binding substrates proteins higher affinity attaching lipid rafts brings close proximity proteins allowing affect signaling pathways cholesterol specifically acts spacer glue lipid rafts absence cholesterol leads dissociation given prevalence cell membranes cholesterol highly involved certain transport processes may influence function ion channels membrane transporters example cholesterol necessary ligand binding activity serotonin addition appears important exocytosis cholesterol modulates properties membrane membrane curvature may regulate fusion vesicles cell membrane may also facilitate recruitment complexes necessary exocytosis given neurons rely heavily exocytosis transmission impulses cholesterol important part nervous one particularly relevant pathway cholesterol takes place hedgehog signaling pathway pathway important embryonic development involved deciding fate cells ie tissue need migrate hedgehog proteins also involved transcription genes regulate cell proliferation differentiation cholesterol important pathway undergoes covalent bonding hedgehog proteins resulting activation without cholesterol signaling activity disrupted cell differentiation may cholesterol precursor many important molecules include bile acids important processing dietary fats oxysterols neurosteroids involved neurotransmission excitation glucocorticoids involved immune inflammatory processes mineralocorticoids osmotic balance sex steroids ie estrogen testosterone wide range function involved genital development finally cholesterol major component myelin protective layer around neurons myelination occurs rapidly prenatal development meaning demand cholesterol biosynthesis given function cholesterol encompasses wide range unlikely symptoms slos due single molecular mechanism molecular effects yet unknown could extrapolated based role cholesterol general negative effects due decreased levels cholesterol increased levels cholesterol precursorsmost notably although structurally similar cholesterol could potentially act substitute effects still patients slos present decreased cholesterol levels particularly brain cholesterol levels rely primarily new synthesis also means sterol derivatives cholesterol would also reduced concentrations example reduced levels neurosteroids may seen slos lipids take part signaling within brain must produced within brain responsible interacting nuclear steroid receptors bind neurotransmittergated ion channels specifically modulate effects gaba nmda receptors resulting calming effects improved memory thus given characteristics slos opposite effects hyperactivity anxiety reduction neurosteroids could influence neurological development furthermore outlined cholesterol important aspect hedgehog signaling lower levels cholesterol hedgehog proteins would undergo necessary covalent modification subsequent activation would result impaired embryonic development may contribute observed physical birth defects slos one particular hedgehog signaling protein sonic hedgehog shh important pattern central nervous system facial features hedgehog proteins may involved development genital tract altered sterol levels slos particularly relevant cell membranes made primarily lipids slos patients may show cell membranes abnormal properties composition reduced cholesterol levels greatly affect stability proteins lipid despite structural similarity unable replace cholesterol lipid addition lack cholesterol contributes increased fluidity cell membrane may cause abnormal granule changes membrane likely contribute changes transport functions observed slos may cause defects ige receptormediated mast cell degranulation cytokine production cells involved allergic immune nmda receptor affected well binding capability hippocampal serotonin cell cell interaction important development may exocytosis synaptic vesicles shown reduced likely due impaired vesicle fusion cell membrane poor vesicle finally cholesterol highly prevalent myelin therefore slos patients show reduced myelination cerebral hemispheres peripheral nerves cranial addition lowered levels cholesterol many symptoms shown slos stem toxic effects known impair intracellular cholesterol transport also increases degradation hmgcoa reductase enzyme catalyzes ratelimiting step cholesterol synthesis leads novel oxysterol steroid derivatives many functions effects yet important finding respect reactive lipid lipid peroxidation results systemic oxidative stress lipid peroxidation known destroy membranes cells membranebound organelles derivative used indicate oxidative stress dhceo formed primary product peroxidation dhceo toxic cortical neuronal glial cells accelerates differentiation oxidative stress thought responsible increased photosensitivity shown slos patients normal uva exposure may lead oxidative stress skin cells given readily oxidized enhances effects uva leading increased membrane lipid oxidation increased production reactive oxygen species typically altered levels cholesterol lead severe symptoms slos levels metabolites also correspond severity mutation nonsense versus missense mutations may still show residual cholesterol synthesis others may however even individuals mutations genotype may still show variability symptoms may due maternal factors transfer cholesterol fetus pregnancy well amount cholesterol present brain barrier forms prenatally rate accumulation excretion toxic metabolites may vary person person maternal apolipoprotein e also implicated individual variability slos although exact nature relationship unknown likely factors contributing wide spectrum effects slos yet characteristic biochemical indicator slos increased concentration reduced cholesterol levels also typical appear disorders well thus prenatally slos diagnosed upon finding elevated sterol ratio fetal tissues increased levels amniotic fluid sterol ratio measured weeks gestation chorionic villus sampling elevated amniotic fluid measured weeks furthermore parental mutations known dna testing amniotic fluid chorionic villus samples may amniocentesis process sampling amniotic fluid chorionic villus sampling performed approximately months pregnancy given slos severe syndrome parents may want choose terminate pregnancy fetus affected amniocentesis chorionic villus sampling leave little time make decision abortions become difficult pregnancy advances also pose severe risks mother baby thus large desire noninvasive midgestation diagnostic examining concentrations sterols maternal urine one potential way identify slos prenatally pregnancy fetus solely responsible synthesizing cholesterol needed produce estriol fetus slos produce cholesterol may use precursors estriol instead creates may show maternal urine novel metabolites due presence normally reduced double bond carbon caused inactivity may used indicators cholesterol derivatives possess double bond position present maternal urine may also indicators slos shown present urine mothers affected fetus unaffected fetus thus used diagnosis pregnadienes originated fetus traveled placenta reaching mother excretion indicates neither placenta maternal organs necessary enzymes needed reduce double bond novel slos goes undetected birth diagnosis may based characteristic physical features well finding increased plasma levels many different ways detecting levels blood plasma one way using lb reagent simple colorimetric assay developed intention use large scale screening treated lb reagent slos samples turn pink immediately gradually become blue normal blood samples initially colorless develop faint blue color although method limitations used give definitive diagnosis appeal much faster method using cell another way detecting gas chromatography technique used separate analyze compounds selected ion monitoring gas chromatographymassspectrometry simgcms sensitive version gas chromatography permits detection even mild cases methods include timeofflight mass spectrometry particlebeam lcms electrospray tandem ms ultraviolet absorbance may used either blood samples amniotic fluid chorionic villus measuring levels bile acids patients urine studying activity tissue culture also common postnatal diagnostic management individuals slos complex often requires team specialists congenital malformations cleft palate corrected treatments yet proven successful randomized studies however anecdotally appear cause currently common form treatment slos involves dietary cholesterol anecdotal reports indicate benefits may result increased growth lower irritability improved sociability less selfinjurious behaviour less tactile defensiveness fewer infections muscle tone less photosensitivity fewer autistic cholesterol supplementation begins dose mgkgday increasing needed administered either consuming foods high cholesterol eggs cream liver purified food grade cholesterol younger children infants may require tube however dietary cholesterol reduce levels cross barrier appear improve developmental one empirical study found cholesterol supplementation improve developmental delay regardless age began likely developmental delays stem malformations brain dietary cholesterol ameliorate due inability cross hmgcoa reductase inhibitors examined treatment slos given catalyzes ratelimiting step cholesterol synthesis inhibiting would reduce buildup toxic metabolites simvastatin known inhibitor hmgcoa reductase importantly able cross barrier reported decrease levels well increase levels increased cholesterol levels due simvastatins effect expression different genes simvastatin increases expression likely leading increased activity also shown increase expression genes involved cholesterol synthesis uptake however benefits dependent amount residual cholesterol synthesis individuals possess less severe mutations demonstrate amount activity people benefit simvastatin therapy still partially functioning enzyme individuals show residual activity homozygous null alleles mutations simvastatin therapy may actually highlights importance identifying specific genotype slos patient administering treatment still unknown simvastatin improve behavioural learning deficits antioxidants inhibit oxidation molecules reduce metabolites previously oxidized given symptoms slos thought result peroxidation derivatives inhibiting peroxidation would likely beneficial effects antioxidants shown increase level lipid transcripts slos cells transcripts play role lipid cholesterol biosynthesis known downregulated slos furthermore vitamin e specifically known decrease dhceo levels indicator oxidative stress slos well present beneficial changes gene expression vitamin e appears powerful antioxidant treating slos mouse models reduced levels oxysterols brain however antioxidants studied animal models slos isolated slos cells thus clinical significance negative side effects still unknown use yet studied treating slos recurring issue whether intellectual behavioral deficits due fixed developmental problems ie fixed brain malformations due ongoing abnormal sterol levels interrupt normal function brain latter true treatments change sterol levels ratios particularly brain likely improve developmental outcome patient however former true treatment likely help symptoms specific developmental common animal used study slos mouse according biocyc cholesterol biosynthesis mice similar humans importantly mice possess enzyme responsible slos hmgcoa reductase rate limiting step cholesterol rats similar mice also used two popular ways animal models slos created first using teratogens second using genetic manipulations create mutations teratogenic models induced feeding pregnant rats mice inhibitors two common inhibitors acid dihydrochloride compounds different chemical physical properties induce similar effects shown induce holoprosencephaly sexual malformations similar seen humans also known cause impairments serotonin receptor another defect commonly seen slos produced lack cholesterol bile acid synthesis seen slos patients homozygous mutations teratogenic models effectively used study slos however present lower levels seen humans explained fact humans experience permanent block activity mice rats treated inhibitors experience transient blocks furthermore different species mice rats resistant teratogens may less effective models teratogenic models commonly used study longterm effects slos survive longer genetic models example one study examined retinal degeneration slos rats occur least one month genetic models slos created knocking gene one study used homologous recombination disrupt mouse embryonic stem cells similar found humans heterozygous mice one mutated allele phentoypically normal crossed produce pups young mice homozygous mutated allele although pups died within first day life due inability feed showed characteristics similar humans slos decreased levels cholesterol increased levels showed less growth smaller birth weights craniofacial malformations less movement many also cleft palate decreased neuronal responses glutamate overall however pups fewer dysmorphic features human patients slos present limb renal adrenal central nervous system malformations explained fact rodents maternal cholesterol cross placenta actually appears essential development fetus humans little maternal cholesterol transferred fetus sum genetic mouse model helpful explain neuropathophysiology many discoveries slos research made using animal models used study different treatment techniques including effectiveness simvastatin studies examined behavioural characteristics attempting explain underlying common finding mouse models slos show abnormal serotonergic development may least partially responsible autistic behaviours seen mouse models also used develop diagnostic techniques multiple studies examined biomarkers result oxidation likely animal models improved lead many discoveries slos named david weyhe smith american pediatrician luc lemli belgian physician john marius opitz germanamerican physician researchers first described symptoms article incorporates public domain material genetics home reference united states national library medicine